Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06029504

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I)

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
115 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate whether Sentinel Node biopsy can be performed without the use of lymphoscintigraphy and with ICG as a mono-tracer in women with vulvar cancer, unifocal tumor \< 4 cm (clinical stage IB and II). Further, to investigate the accuracy of combined PET-CT and ultrasound (US) of the groins with US-guided biopsy of suspicious lymph nodes for the identification of macro-metastases in women with vulvar cancer, unifocal tumor \< 4 cm.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2023-09-08
Last updated
2023-12-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06029504. Inclusion in this directory is not an endorsement.

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) (NCT06029504) · Clinical Trials Directory